Alan S. Goldstein

All filings by Alan S. Goldstein on record concern Bradley Pharmaceuticals Inc. In total, 4 filings cover trades dated 21 February 2008.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 21 February 2008: a transaction of €272k, in Bradley Pharmaceuticals Inc. Most trades are made public on the day they happen. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.